Literature DB >> 7030751

Effect of minoxidil on sympathetic nervous activity in clonidine-treated hypertensive patients.

M Velasco, A Urbina-Quintana, E Hernández, A Ramírez, R Aliendres, J Morillo, O Hernández-Pieretti.   

Abstract

The effects of clonidine and minoxidil on sympathetic nervous activity has been studied in 10 patients with accelerated or resistant hypertension. Clonidine 150 to 900 micrograms/day caused a significant decrease in blood pressure of 18.6 mm Hg, of heart rate 16.4 beats/min, of plasma renin activity 1.13ng/ml h, and of urinary noradrenaline excretion 11.55 micrograms/day, and a significant lengthening of the pre-injection period of 12.4 ms. Minoxidil 5 to 22.5 micrograms/day caused a further significant decrease in blood pressure of 24.2 mm Hg, and significant increases in heart rate 8.2 beats/min, plasma renin activity 1.68 ng/ml h and of urinary noradrenaline excretion 5.0 micrograms/day, and a significant shortening of the pre-ejection period of 20.6 ms. Neither clonidine nor minoxidil altered plasma dopamine beta-hydroxylase activity or the cardiovascular responses to treadmill exercise. It is concluded that clonidine is a useful alternative agent to block a minoxidil-induced increase in sympathetic nervous activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030751     DOI: 10.1007/bf00618775

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  EXERCISING TESTING IN ADULT NORMAL SUBJECTS AND CARDIAC PATIENTS.

Authors:  R A BRUCE; J R BLACKMON; J W JONES; G STRAIT
Journal:  Pediatrics       Date:  1963-10       Impact factor: 7.124

3.  Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.

Authors:  M Velasco; K O'Malley; N W Robie; J Wells; Z H Israili; J L McNay
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

4.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

5.  Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

Authors:  R Zacest; E Gilmore; J Koch-Weser
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

6.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

7.  Systolic time intervals in cardiac disease. I.

Authors:  A M Weissler; C L Garrard
Journal:  Mod Concepts Cardiovasc Dis       Date:  1971-01

8.  A sensitive enzymatic assay for dopamine- -hydroxylase.

Authors:  P B Molinoff; R Weinshilboum; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

Review 9.  The central action of antihypertensive drugs, mediated via central alpha-receptors.

Authors:  P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

10.  Clonidine and the vasodilating beta blocker antihypertensive drug interaction.

Authors:  W A Pettinger; H C Mitchell; H G Güllner
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

View more
  1 in total

1.  Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.

Authors:  M Velasco; A Urbina-Quintana; J Morillo; H Vizcarrondo; A Ramirez; E Hernández; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.